PRESS RELEASE published on 01/19/2024 at 23:05, 1 year 10 months ago ROSEN, A LEADING NATIONAL FIRM, Encourages British American Tobacco p.l.c. Investors to Inquire About Securities Class Action Investigation - BTI The Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of British American Tobacco p.l.c. (NYSE: BTI) shareholders for possible misleading business information. Shareholders who have purchased British American Tobacco securities may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. To join the prospective class action seeking recovery of investor losses, individuals can visit their website or contact their toll-free number or email for more information. The Rosen Law Firm has a successful track record in securities class actions and shareholder derivative litigation, including achieving the largest ever securities class action settlement against a Chinese Company and recovering hundreds of millions of dollars for investors. Rosen Law Firm Securities Class Action Investor Rights British American Tobacco Shareholder Compensation
PRESS RELEASE published on 01/19/2024 at 23:04, 1 year 10 months ago ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ON Semiconductor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - ON The Rosen Law Firm, a leading global investor rights law firm, encourages ON Semiconductor Corporation investors to secure counsel before the important deadline in the securities class action. If you purchased onsemi common stock during the Class Period, you may be entitled to compensation. The Rosen Law Firm has a track record of success in leadership roles and represents investors worldwide. Act now to protect your rights and seek qualified counsel. Rosen Law Firm Securities Class Action Investor Rights ON Semiconductor Corporation Compensation
PRESS RELEASE published on 01/19/2024 at 22:02, 1 year 10 months ago ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brooge Energy Limited Investors to Inquire About Securities Class Action Investigation - BROG The Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of shareholders of Brooge Energy Limited. The firm believes that Brooge may have issued misleading business information to the investing public, resulting in potential financial losses for investors. Interested investors are encouraged to contact the firm to inquire about joining the prospective class action and seeking recovery of investor losses without payment of any out-of-pocket fees or costs. Through its extensive experience and successful track record, The Rosen Law Firm has recovered substantial amounts for investors in securities class actions and shareholder derivative litigation, making them a reliable choice for investors seeking legal representation in such matters. Rosen Law Firm Investor Rights Securities Claims Brooge Energy Limited Class Action Investigation
PRESS RELEASE published on 01/19/2024 at 22:02, 1 year 10 months ago ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important January 30 Deadline in Securities Class Action - LPSN Rosen Law Firm, a global investor rights law firm, encourages LivePerson, Inc. investors to secure counsel before the important January 30 deadline in the securities class action. The lawsuit alleges misleading statements and withholding of material information by LivePerson, leading to financial damages for investors. Investors may be entitled to compensation and are urged to seek qualified counsel to protect their rights. Rosen Law Firm Securities Class Action Investor Rights LivePerson Inc. Financial Damages
PRESS RELEASE published on 01/19/2024 at 21:04, 1 year 10 months ago ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX The Rosen Law Firm, a global investor rights law firm, has announced the filing of a class action lawsuit on behalf of BioNTech SE investors. The lawsuit alleges that BioNTech made materially false and misleading statements regarding its business and operations, overstating demand for its COVID-19 vaccine and accumulating excess inventory. Investors who purchased BioNTech securities during the specified period may be entitled to compensation and are encouraged to seek qualified counsel before the March 12, 2024 deadline. Rosen Law Firm BioNTech SE Securities Class Action Investor Rights COVID-19 Vaccine
Published on 12/05/2025 at 02:35, 10 hours 13 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 48 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 43 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 48 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 43 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 48 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 48 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 34 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 2 hours 18 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 08:45, 4 hours 3 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 48 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 3 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 4 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health